Company News
Solara Q1 FY27 Results Analyst Conference Call
Solara Active Pharma Sciences scheduled a conference call for July 23, 2026, to discuss its unaudited Q1 FY27 financial results.
Management participants include MD & CEO Sandeep Rao and CFO Sarat Kuma
